Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow

Abatacept is the only T cell co-stimulation modulator approved thus far for the treatment of moderate-to-severe rheumatoid arthritis (RA) and is licensed for use in patients with an inadequate response to methotrexate (MTX) and/or anti-tumor necrosis factor (anti-TNF) therapy. The upstream mechanism...

Descripción completa

Detalles Bibliográficos
Autor principal: Schiff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Rheumatoid Arthritis (J Kay, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566119/
https://www.ncbi.nlm.nih.gov/pubmed/28936386
http://dx.doi.org/10.1007/s40674-015-0029-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566119/
https://www.ncbi.nlm.nih.gov/pubmed/28936386
http://dx.doi.org/10.1007/s40674-015-0029-0

Ejemplares similares